Q3 2025 Cibus Inc Earnings Call Transcript

Nov 13, 2025 / 09:30 PM GMT

Release Date Price: $1.25 (-7.41%)

Transcript 10-Q8-K

Key Points

Positve

Cibus Inc (CBUS) has signed 7 rice customer agreements in the USA and Latin America, representing 5 to 7 million addressable acres for their rice herbicide tolerant traits.
The company has strengthened its board with the appointment of Kimberly Box and Craig Wisner, bringing valuable expertise in technology operations and sustainable agriculture.
Cibus Inc (CBUS) achieved critical milestones in their biofragrance program, completing pre-commercial pilot runs for two products, positioning them for commercial scale expansion.
The company has made significant progress in regulatory approvals, including the California Rice Commission's approval for gene-edited rice planting, enhancing global market access.
Cibus Inc (CBUS) has successfully reduced operating expenses by almost $5 million in the first nine months of 2025, demonstrating disciplined capital allocation and extending their cash runway.

Negative

Revenue for Q3 2025 was $615,000, a decrease from $1.7 million in the same period last year, reflecting timing of partner-funded program activities.
Research and development expenses remain high at $10.8 million for Q3, despite a decrease from the previous year, indicating ongoing financial pressure.
The company faces challenges in the regulatory environment, with slower-than-expected progress in finalizing EU regulations for gene-edited products.
Cibus Inc (CBUS) has a limited cash runway, with existing cash and equivalents expected to fund operations only into early Q2 2026, necessitating potential financing transactions.
The commercialization of biofragrance products is expected to generate only single-digit million revenues in 2026, indicating a slower ramp-up than anticipated.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CBUS.OQ - Cibus Inc
Q3 2025 Cibus Inc Earnings Call
Nov 13, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
.

.

.

.

.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
To all sites on hold, we do appreciate your patience and holding and ask that you please continue to stand by. Thanks again, everyone.

--------------------------------------------------------------------------------
Unidentified_1 [3]
--------------------------------------------------------------------------------
Hum.

.

--------------------------------------------------------------------------------
Unidentified_2 [4]
------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.